Here are three things to know.
- The Quantiferon-TB Gold Plus test is designed to detect latent tuberculosis in patients.
- The blood test offers a broad look into an individual’s immune response to tuberculosis, according to a news release.
- Qiagen plans to launch the new test later this year.
More articles on supply chain:
7 drugmakers in the headlines
4 ways hospitals can lower inpatient drug costs
6 must-reads for supply chain leaders this week
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
